Lower doses of carvedilol in Japanese heart failure patients with reduced ejection fraction could show the potential to be non-inferior to higher doses in US patients: An international collaborative observational study.

Autor: Maeda, Makiko^1,2,3 (AUTHOR) makikom@phs.osaka-u.ac.jp, Humber, Douglas^4,5 (AUTHOR), Hida, Eisuke⁶ (AUTHOR), Ohtani, Tomohito⁷ (AUTHOR), Wang, Guannan⁴ (AUTHOR), Wu, Tong² (AUTHOR), Takeda, Shiori¹ (AUTHOR), Situ, Jacinta N.² (AUTHOR), Hayashi, Jun¹ (AUTHOR), Nonen, Shinpei⁸ (AUTHOR), Takeda, Toshihiro⁹ (AUTHOR), Okamoto, Hiroshi¹⁰ (AUTHOR), Hori, Masatsugu¹¹ (AUTHOR), Sakata, Yasushi⁷ (AUTHOR), Fujio, Yasushi^12,13 (AUTHOR), Tsunoda, Shirley M.^4,5 (AUTHOR) makikom@phs.osaka-u.ac.jp

Publikováno v: PLoS ONE. 3/7/2024, Vol. 19 Issue 3, p1-14. 14p.

Abstract 13725: The Dose Difference of Carvedilol for Heart Failure Management Between Asian-Americans and Japanese Could Show No Difference in the Improvement of Heart Function

Autor: Maeda, Makiko, Humber, Douglas, Hida, Eisuke, Ohtani, Tomohito, Wang, Guannan, Wu, Tong, Hayashi, Jun, Situ, Jacinta N, Takeda, Shiori, Okamoto, Hiroshi, Takeda, Toshihiro, Hori, Masatsugu, Sakata, Yasushi, Fujio, Yasushi, Tsunoda, Shirley

Publikováno v: Circulation (Ovid); November 2022, Vol. 146 Issue: Supplement 1 pA13725-A13725, 1p

Anticoagulant Use in High Stroke-Risk Patients With Nonvalvular Atrial Fibrillation.

Autor: Nguyen HK; A 2018 PharmD candidate, University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California at the time of this writing., Humber D; A 2018 PharmD candidate, University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California at the time of this writing., Checkoway H; A 2018 PharmD candidate, University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California at the time of this writing., Blanchard D; A 2018 PharmD candidate, University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California at the time of this writing., Watanabe JH; A 2018 PharmD candidate, University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California at the time of this writing.

Publikováno v: The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists [Consult Pharm] 2018 Sep 01; Vol. 33 (9), pp. 521-530.